Patching Strategies for Lazy Eye
(ATS22 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best way to treat lazy eye (amblyopia) in children using glasses and eye patches. Researchers aim to determine if starting glasses and patches simultaneously is as effective as starting with glasses and adding patches only if necessary. Children aged 3 to 13 who have not received treatment for lazy eye and have vision issues like uneven eyesight or crossed eyes may qualify. Participants will wear glasses (also known as spectacles or eyeglasses) full-time, and some will also wear an eye patch for a few hours daily. The goal is to identify the most effective approach to improve vision in children with amblyopia. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment for amblyopia.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that participants must be willing to forego contact lens wear during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both glasses and patching are generally safe and well-tolerated treatments for amblyopia, also known as lazy eye. Glasses, a common treatment, are safe for children, help correct vision, and have no major side effects.
Studies have found that patching, which involves covering the stronger eye with a patch to strengthen the weaker eye, is also safe. Specifically, one study found that wearing a patch for two hours a day can improve vision in children with moderate to severe lazy eye. Although some children might resist wearing the patch, this treatment poses no serious health risks.
Both glasses and patching have been safely used in children for many years, making them reliable options for treating lazy eye.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these patching strategies for lazy eye because they offer two innovative approaches to treatment. The simultaneous treatment combines full-time glasses with part-time patching, aiming for continuous improvement with minimal disruption to daily life. On the other hand, the sequential treatment starts with full-time glasses and only adds patching if necessary, which could mean fewer interventions for some patients. Both strategies focus on personalizing care and potentially reducing the burden of treatment compared to traditional full-time patching, making them promising alternatives for managing lazy eye.
What evidence suggests that this trial's treatments could be effective for lazy eye?
Studies have shown that wearing glasses can improve vision in children with amblyopia, often called "lazy eye." Glasses alone have been found to enhance vision in the weaker eye by about 1.8 lines on an eye chart for children aged 3 to 6, and 0.8 lines for those aged 7 to 12. Another method, patching, involves covering the stronger eye to encourage the weaker one to work harder. Research shows that wearing a patch for two hours a day can significantly improve vision, with some studies noting an average improvement of 3.6 lines for more severe cases.
In this trial, participants will be assigned to one of two treatment strategies: the simultaneous treatment arm, which includes full-time spectacle correction and part-time patching for 2 hours per day, or the sequential treatment arm, which starts with full-time spectacle correction and adds patching only if needed. Combining glasses and patching is a common way to achieve the best results.26789Who Is on the Research Team?
Vivian Manh
Principal Investigator
Seattle Children's Hospital, University of Washington
Michael Gray
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Are You a Good Fit for This Trial?
This trial is for children aged 3 to under 13 with lazy eye (amblyopia) who haven't been treated before. It's open to those with a certain type of misalignment in their eyes (strabismus), a difference in prescription between the eyes, or both. Kids can't join if they have severe nearsightedness, previous eye surgery, allergies to silicone or adhesive patches, or developmental delays that could affect treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants are prescribed spectacles and return for a baseline visit to confirm eligibility before randomization
Treatment
Participants receive either sequential or simultaneous treatment with spectacles and patching, with follow-up visits every 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Glasses
- Patching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jaeb Center for Health Research
Lead Sponsor
National Eye Institute (NEI)
Collaborator
Pediatric Eye Disease Investigator Group
Collaborator